BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 990 filers reported holding BAXTER INTL INC in Q4 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,428,260 | -85.0% | 31,349 | -86.7% | 0.04% | -85.9% |
| Q1 2023 | $9,527,503 | -33.6% | 234,899 | -16.5% | 0.26% | -35.6% |
| Q4 2022 | $14,345,965 | +842.0% | 281,459 | +1087.2% | 0.41% | +498.5% |
| Q2 2022 | $1,523,000 | -88.5% | 23,707 | -86.1% | 0.07% | -89.0% |
| Q1 2022 | $13,208,000 | +3210.3% | 170,339 | +3561.6% | 0.62% | +2380.0% |
| Q4 2021 | $399,000 | -84.1% | 4,652 | -85.1% | 0.02% | -87.5% |
| Q3 2021 | $2,517,000 | -30.9% | 31,298 | -30.8% | 0.20% | -34.9% |
| Q2 2021 | $3,640,000 | -36.0% | 45,220 | -36.2% | 0.31% | -49.0% |
| Q4 2020 | $5,684,000 | -23.2% | 70,841 | -23.0% | 0.60% | +26.5% |
| Q3 2020 | $7,397,000 | +23.8% | 91,975 | +32.6% | 0.48% | +14.7% |
| Q2 2020 | $5,974,000 | +183.8% | 69,380 | +167.6% | 0.42% | +171.2% |
| Q1 2020 | $2,105,000 | -51.5% | 25,922 | -50.1% | 0.15% | -40.5% |
| Q4 2019 | $4,343,000 | +105.8% | 51,943 | +62.0% | 0.26% | +94.7% |
| Q4 2018 | $2,110,000 | -26.5% | 32,054 | -13.9% | 0.13% | -38.9% |
| Q3 2018 | $2,870,000 | +41.3% | 37,223 | +35.3% | 0.22% | +53.2% |
| Q2 2018 | $2,031,000 | -35.2% | 27,505 | -42.9% | 0.14% | -35.6% |
| Q1 2018 | $3,135,000 | +79.2% | 48,196 | +78.1% | 0.22% | +14.1% |
| Q4 2017 | $1,749,000 | +30.7% | 27,063 | +22.5% | 0.19% | -47.5% |
| Q2 2017 | $1,338,000 | +198.7% | 22,100 | +102.8% | 0.37% | +603.8% |
| Q1 2016 | $448,000 | -56.8% | 10,900 | -59.9% | 0.05% | -42.9% |
| Q4 2015 | $1,038,000 | -72.7% | 27,200 | -76.5% | 0.09% | -72.2% |
| Q3 2015 | $3,804,000 | +113.6% | 115,800 | +345.4% | 0.33% | +79.7% |
| Q1 2015 | $1,781,000 | – | 26,000 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |